<DOC>
	<DOCNO>NCT02285036</DOCNO>
	<brief_summary>A newly 23-valent pneumococcal polysaccharide vaccine develop promising safety immunogenicity demonstrate phase III trial China . A large scale , double blind , randomize , PNEUMOVAX 23 ( Merck &amp; Co. , Inc. ) control phase 3 clinical trial conduct .</brief_summary>
	<brief_title>Safety Immunogenicity Newly 23-valent Pneumococcal Polysaccharide Vaccine Chinese Adults Children</brief_title>
	<detailed_description>The World Health Organization ( WHO ) estimate 800 000 child young 5 year die pneumococcal disease 2000 , make lead vaccine-preventable cause death . Pneumococcal polysaccharide vaccine progress 2-valent vaccine current 23-valent vaccine , available since early 1980s . The 23-valent vaccine include serotypes account 72 % 95 % invasive pneumococcal disease , depend geographic area . Many country add pneumococcal polysaccharide vaccine exist national immunization program recommend people age 65 year old individual age 2-64 increased risk pneumococcal disease . A newly 23-valent pneumococcal polysaccharide vaccine develop promising safety immunogenicity demonstrate phase III trial China . A large scale , double blind , randomize , PNEUMOVAX 23 ( Merck &amp; Co. , Inc. ) control phase 3 clinical trial conduct .</detailed_description>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Healthy participant older 2 year recruit enrolled September October 2012 . Participants axillary temperature less Celsius 37 degree Not yet receive pneumococcal vaccine prevention product within 7 day . Exclusion criterion know primary secondary immunodeficiency Allergy Severe cardiovascular disease bleed disorder Receipt immunoglobulin blood product within one month .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>